Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing lansoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* infection. Lansoprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics.
## Primary Indications
Eradication of *Helicobacter pylori* in patients with peptic ulcer disease.
## Adult Dosing
**Sompraz HP (lansoprazole 30 mg / amoxicillin 1 g / clarithromycin 500 mg)**: One dose pack (containing one lansoprazole 30 mg capsule, two amoxicillin 500 mg capsules, and one clarithromycin 500 mg tablet) twice daily for 14 days.
* The amoxicillin components should be taken as two 500 mg capsules at each dosing time.
* The clarithromycin component should be taken as one 500 mg tablet at each dosing time.
* The lansoprazole component should be taken as one 30 mg capsule at each dosing time.
* **Total daily dose:** Lansoprazole 60 mg, Amoxicillin 2 g, Clarithromycin 1 g.
* **Maximum daily dose:** Not applicable for this fixed combination regimen as prescribed.
## Pediatric Dosing
Dosing for Sompraz HP in pediatric patients has not been established.
## Dose Adjustments
No specific dose adjustments are routinely recommended for renal or hepatic impairment for this combination product. However, individual components may require adjustment if used separately.
## Contraindications
* Hypersensitivity to lansoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of cholestatic jaundice/hepatic dysfunction associated with prior amoxicillin or clarithromycin use.
* Severe renal impairment (for amoxicillin component, if used separately).
* Severe hepatic impairment (for clarithromycin component, if used separately).
* Use in patients with macrolide resistance or specific contraindications to clarithromycin.
## Adverse Effects
**Common:** Diarrhea, nausea, vomiting, abdominal pain, taste perversion, headache, rash.
**Serious:** *Clostridioides difficile*-associated diarrhea, severe allergic reactions (anaphylaxis), liver dysfunction (hepatitis, cholestasis), *Stevens-Johnson syndrome*, *toxic epidermal necrolysis*, *QT prolongation* (clarithromycin).
## Key Drug Interactions
* **Lansoprazole:** May decrease the absorption of drugs requiring acidic environments (e.g., ketoconazole, itraconazole, iron salts). May increase the effect of certain drugs by altering gastric pH.
* **Amoxicillin:** Can decrease the efficacy of oral contraceptives. Probenecid can decrease renal excretion of amoxicillin.
* **Clarithromycin:** Potent inhibitor of CYP3A4. Can increase serum concentrations of numerous drugs metabolized by CYP3A4 (e.g., warfarin, carbamazepine, cyclosporine, tacrolimus, statins, certain calcium channel blockers, colchicine). Avoid co-administration with colchicine in patients with renal or hepatic impairment. May prolong QT interval.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Monitor for diarrhea; assess for *C. difficile*-associated diarrhea.
* Monitor liver function tests, particularly with prolonged use or in patients with pre-existing liver disease.
* Monitor for signs of drug interactions, especially with clarithromycin.
## Clinical Pearls
* This regimen is typically prescribed for 14 days to ensure adequate *H. pylori* eradication.
* Patients should be advised to complete the full course of therapy, even if they feel better.
* Probiotics may be considered to help reduce the incidence of antibiotic-associated diarrhea.
* Ensure patients do not have a known allergy to penicillin or macrolides.
* Resistance to clarithromycin can affect eradication rates.
***
*This information is intended for healthcare professionals and does not replace the need to consult the most current prescribing information, institutional protocols, or patient-specific factors before making any treatment decisions.*
